Personalised health care 9783030523985

Варианты приобретения

Цена: 6986.00р.
Кол-во:
Наличие: Поставка под заказ. Есть в наличии на складе поставщика.
Склад Америка: Есть
При оформлении заказа до: 2025-07-28
Ориентировочная дата поставки: Август-начало Сентября
При условии наличия книги у поставщика.

Добавить в корзину

в Мои желания

Название: Personalised health care
ISBN: 9783030523985
Издательство: Springer
Классификация:

Этика и философия нравов

Медицинское право и законодательство о медицинском обслуживании

Здравоохранение и профилактическая медицина

Службы системы здравоохранения

Медицинская генетика

Науки о жизни (медико-биологические): общие вопросы

Генетика (немедицинская)

ISBN-10: 3030523985
Обложка/Формат: Paperback
Страницы: 120
Вес: 0.24 кг.
Дата издания: 24.11.2020
Серия: Springerbriefs in public health
Язык: English
Издание: 1st ed. 2020
Иллюстрации: 13 illustrations, color; 2 illustrations, black and white; xvii, 126 p. 15 illus., 13 illus. in color.
Размер: 23.39 x 15.60 x 0.76 cm
Читательская аудитория: Professional & vocational
Подзаголовок: Fostering precision medicine advancements for gaining population health impact
Ссылка на Издательство: Link
Рейтинг:
Поставляется из: Германии
Описание: Introduction (Boccia)
1. Chapter 1: Identification of biomarkers for the prevention of chronic disease (Editors: Adany, Boccia).
1.1 Van Duijn (Identification of biomarkers for primary and secondary prevention - Liu)1.2 Boccia (Identification of biomarkers for tertiary prevention - Mariani, Giraldi, Pastorino)1.3 Adany (Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Specific Diseases)1.4 Giordano Bottа - Allelica (Non Academic Vision) Recommendation 1
Personalised interventions for the prevention of chronic diseases require robust evidence of efficacy and/or effectiveness of the new technology when implemented in health care.

2. Chapter 2: Evaluation of predictive genomic applications (Editor: Villari)
2.1 The economic evaluation of genetic/genomic applications (DAndrea)2.2 The HTA approach for the evaluation of genetic/genomic applications (Pitini)2.3 Training needs in genomics of Public Health Professionals (Rosso)
Recommendation 2A comprehensive evaluation of the value (outcomes/cost) of the new technology should also include evidence on the social aspects, and context-related dimensions to better support the clinical decision-making process. Genetic or genomic applications with evidence of efficacy, effectiveness, and cost-effectiveness should be implemented in clinical and public health practice.

3. Chapter 3: Ethico-legal and policy issues surrounding personalised medicine (Editor: Sandor)
3.1 Zawati (Ethical issue) 3.2 Calabro, Hoxaij, Boccia (Policy issue, with a focus on training in genomics for healthcare professionals)3.3 Calabro, Sassano, Boccia (Policy issue, with a focus on citizens and DTC)3.4 Sandor (Legal issue)
Recommendation 3The era of genomics requires that we clarify and validate the obligations and responsibilities of the research community, research participants, and the general public including patients through collaboration and dissemination of high-quality ethical, policy, and legal analysis.

4. Chapter 4: Roles and responsibilities of stakeholders in informing healthy individuals on their genome: a sociotechnical analysis (Editor: Cornel)
(Martina Cornel, Tessel Rigter, and Carla van El)4.1 Responsible translation of new genomic technologies in the context of screening of healthy adults4.2 Examples from hereditary cardiovascular diseases and hereditary cancers
Recommendation 4 A dedicated effort is necessary to stimulate further implementation of evidence-based interventions in health care, such as testing of family members in cases of hereditary cancers or cardiovascular diseases.
5. Chapter 5: Identification of organizational models for the provision of predictive genomic applications (Editor: De Vito)
5.1 De Vito/Unim (Delivery models for genetic/genomic applications)5.2 Cornel (Barriers and Facilitating Factors for Implementation of Genetic Services)5.3 Gray/Jani (Design systems that integrate genomic information to deliver personalised care)5.4 Roldan (Clinical decision support tool to assist physicians in the screening of genetic diseases)
Recommendation 5 The integration of genomic sciences in other medical spec

Personalised health care,